Better Plant Sciences Announces Website Launch and Strategic Plan to Grow Direct-to-Consumer Sales Post published:August 27, 2020 Post category:Press Release
Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 Post published:August 26, 2020 Post category:Press Release
Psychedelics & Functional Mushroom Co Silo Wellness Inches Closer to Go-Public Post published:August 26, 2020 Post category:Press Release
Mydecine Innovations Group Announces Extended Lock-Up Arrangement Post published:August 25, 2020 Post category:Press Release
MindMed Announces First-Ever Clinical Trial Combining MDMA and LSD Post published:August 25, 2020 Post category:Press Release
Better Plant Sciences Submits Application for Ayurvedic Skin Ointment to Combat Infectious Disease Post published:August 25, 2020 Post category:Press Release
ATAI Life Sciences launches EmpathBio to treat post-traumatic stress disorder with novel MDMA product Post published:August 24, 2020 Post category:Press Release
Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation Post published:August 24, 2020 Post category:Press Release
Ehave Announces Plans to Accelerate the Monetization of its Proprietary Digital Health Platform Post published:August 24, 2020 Post category:Press Release
Hollister Biosciences Inc. Reports Second Quarter 2020 Results Post published:August 24, 2020 Post category:Financials/Press Release